相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
Elena Campello et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Association between glucose-lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy
Yoojin Noh et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Bleeding incidence and risk factors among cancer patients treated with anticoagulation
Dana E. Angelini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Venous thromboembolism in cancer patients: Still looking for answers
Roua Anamaria Iorga et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
Yeo Jin Choi et al.
CANCER MANAGEMENT AND RESEARCH (2019)
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Frits I. Mulder et al.
HAEMATOLOGICA (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
Andrew B. Song et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2019)
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy
Hanny Al-Samkari et al.
BLOOD ADVANCES (2019)
Contact System Activation and Cancer: New Insights in the Pathophysiology of Cancer-Associated Thrombosis
E. Campello et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
Sooyoung Shin et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
Hanny Al-Samkari et al.
CANCERS (2018)
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
Norbaini Binti Abdol Razak et al.
CANCERS (2018)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Gender differences in cancer patients with acute venous thromboembolism
Francisco Martin-Martos et al.
THROMBOSIS RESEARCH (2015)
Anticoagulation Drug Therapy: A Review
Katherine Harter et al.
WESTERN JOURNAL OF EMERGENCY MEDICINE (2015)
Age and Cancer Risk A Potentially Modifiable Relationship
Mary C. White et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2014)
Anticoagulant-related gastrointestinal bleeding-could this facilitate early detection of benign or malignant gastrointestinal lesions?
Andreas Clemens et al.
ANNALS OF MEDICINE (2014)
Tissue factor in tumor microenvironment: a systematic review
Xiao Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment
R. E. J. Roach et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty
Garrett B. Aikens et al.
WORLD JOURNAL OF ORTHOPEDICS (2014)
Activation of blood coagulation in cancer: implications for tumour progression
Luize G. Lima et al.
BIOSCIENCE REPORTS (2013)
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States
Alok A. Khorana et al.
CANCER (2013)
Cancer-associated thrombosis
Gregory C. Connolly et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Management of venous thromboembolism in patients with cancer
G. Agnelli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Tissue factor in tumour progression
Janusz Rak et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2009)
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
Effectiveness of warfarin among patients with cancer
Adam J. Rose et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis
Simon McRae et al.
LANCET (2006)
Incidence of venous thrombosis in a large cohort of 66 329 cancer patients:: results of a record linkage study
JW Blom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Risk factors for venous thromboembolism
FA Anderson et al.
CIRCULATION (2003)
Venous thromboembolism and cancer: Risks and outcomes
AYY Lee et al.
CIRCULATION (2003)
分享论文
